Abstract
Objective To evaluate if replication-defective herpes simplex virus mediated kynurenine aminotransferase Ⅱ (HSV-KATⅡ) could inhibit detrusor overactivity (DO) in rats with spinal cord injury by bladder wall injection. Methods From June 2012 to July 2013, 48 male Wistar rats with T10 spinal cord transection (SCT) were randomly divided into normal saline group, HSV group and HSV-KATⅡ group (n=16 each group). Normal saline (40 μl), HSV or HSV-KAT Ⅱ(40 μl, 1×107 plaque forming unit viruses) was injected into the rat bladder wall of according group by 1 week after SCT. Three weeks after injection, cystometry was performed and the virus transfected efficiency, expression of KATⅡ in L6–S1 dorsal root ganglia were examined. Results The DO number, DO amplitude, maximum voiding pressure and volume inducing voiding were decreased significantly by 59.6%–61.1%, 21.6%–24.2%, 30.3%–34.4% and 44.1%–46.5% (P 0.05). The relative intensity of KATⅡ protein (0.50±0.13 versus 0.28±0.07, P<0.05) and mRNA (0.78±0.06 versus 0.51±0.08, P<0.01) were increased significantly in HSV-KATⅡgroup than those in HSV group. Conclusion HSV-KATⅡ bladder wall injection inhibits DO and may improve detrusor-sphincter dyssynergia in rats with spinal cord injury. Key words: Spinal cord injuries; Detrusor overactivity; Herpes simplex virus; Kynurenine aminotransferase; Rats, Wistar
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
